Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Becherer

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Neuro-Oncology|June 20, 2003
Psychometric- and quality-of-life assessment in long-term glioblastoma survivorsManuela Schmidinger, Leo Linzmayer, Alexander Becherer, et al.
European Journal of Radiology|December 26, 2008
Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PETPhilipp Peloschek, Clemens Novotny, Christina Mueller-Mang, et al.
European Journal of Radiology|April 20, 2005
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residualsAlexander Becherer, Maria De Santis, Georgios Karanikas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2003
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionineAlexander Becherer, Georgios Karanikas, Monica Szabó, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trialMaria De Santis, Alexander Becherer, Carsten Bokemeyer, et al.
European Journal of Immunology|September 28, 2007
The presence of MOMA-2+ macrophages in the outer B cell zone and protection of the splenic micro-architecture from LPS-induced destruction depend on secreted IgMMichael B Fischer, Beate Rüger, Christine Vaculik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancerStefan Wachter, Sandra Tomek, Amir Kurtaran, et al.
Nuklearmedizin. Nuclear Medicine|July 16, 2016
[Therapy of bone metastases with radium-223. German guidelines]Thorsten D Pöppel, Michael Andreeff, Alexander Becherer, et al.
Nuklearmedizin. Nuclear Medicine|April 9, 2021
[Joint DGN, OGNMB and SGNM S1 guideline for radiosynoviorthesis]Michael Gabriel, Thorsten D Pöppel, Lutz S Freudenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2017
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancerThorsten D Poeppel, Daria Handkiewicz-Junak, Michael Andreeff, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Neuro-Oncology|June 20, 2003
Psychometric- and quality-of-life assessment in long-term glioblastoma survivorsManuela Schmidinger, Leo Linzmayer, Alexander Becherer, et al.
European Journal of Radiology|December 26, 2008
Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PETPhilipp Peloschek, Clemens Novotny, Christina Mueller-Mang, et al.
European Journal of Radiology|April 20, 2005
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residualsAlexander Becherer, Maria De Santis, Georgios Karanikas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2003
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionineAlexander Becherer, Georgios Karanikas, Monica Szabó, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trialMaria De Santis, Alexander Becherer, Carsten Bokemeyer, et al.
European Journal of Immunology|September 28, 2007
The presence of MOMA-2+ macrophages in the outer B cell zone and protection of the splenic micro-architecture from LPS-induced destruction depend on secreted IgMMichael B Fischer, Beate Rüger, Christine Vaculik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancerStefan Wachter, Sandra Tomek, Amir Kurtaran, et al.
Nuklearmedizin. Nuclear Medicine|July 16, 2016
[Therapy of bone metastases with radium-223. German guidelines]Thorsten D Pöppel, Michael Andreeff, Alexander Becherer, et al.
Nuklearmedizin. Nuclear Medicine|April 9, 2021
[Joint DGN, OGNMB and SGNM S1 guideline for radiosynoviorthesis]Michael Gabriel, Thorsten D Pöppel, Lutz S Freudenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2017
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancerThorsten D Poeppel, Daria Handkiewicz-Junak, Michael Andreeff, et al.
Pageof 3